aiqbench analysis
This study presents FD-SCoPE, a language-model framework that enables clinicians to interrogate evidence tables with verifiable, feedback-driven responses for attributes not explicitly recorded in the data. By coupling executable queries with expert corrections, the system achieves high accuracy in retrieving relevant trial records and deriving complex clinical insights from oncology datasets. The approach demonstrates how integrating verified programs and human feedback can provide auditable access to trial evidence, advancing the practical application of AI in medical research.
Answering clinicians' questions over trial evidence tables with verifiable, feedback-driven language models
arXiv:2610.02576v1 Announce Type: new Abstract: Systematic reviews condense clinical trials into evidence tables, yet clinicians can interrogate these tables only through database queries, and many questions concern attributes that the table does not record, such as a drug's target class or a harmonised endpoint. Here we introduce FD-SCoPE, a language-model framework that answers both kinds of question, exposes the query, the selected trials and the derivation rule behind every answer, and learns from expert corrections. On an oncology evidence table of 159 immune checkpoint inhibitor trial records, FD-SCoPE completed all 140 clinician-style tasks (alternatives, 90.7-97.9%). For questions needing derived attributes it retrieved 99.3% of relevant trial records at a positive predictive value of 89.8% and outperformed four alternative approaches (derived-value F1 77.7% versus 64.8-73.4%). Corrections on 299 questions, simulated from reference answers, raised F1 on 1,201 unseen questions from 77.9% to 84.9%. Language models coupled with executable queries, verified programs and expert feedback can give clinicians auditable access to trial evidence.
Abstract:Systematic reviews condense clinical trials into evidence tables, yet clinicians can interrogate these tables only through database queries, and many questions concern attributes that the table does not record, such as a drug's target class or a harmonised endpoint. Here we introduce FD-SCoPE, a language-model framework that answers both kinds of question, exposes the query, the selected trials and the derivation rule behind every answer, and learns from expert corrections. On an oncology evidence table of 159 immune checkpoint inhibitor trial records, FD-SCoPE completed all 140 clinician-style tasks (alternatives, 90.7-97.9%). For questions needing derived attributes it retrieved 99.3% of relevant trial records at a positive predictive value of 89.8% and outperformed four alternative approaches (derived-value F1 77.7% versus 64.8-73.4%). Corrections on 299 questions, simulated from reference answers, raised F1 on 1,201 unseen questions from 77.9% to 84.9%. Language models coupled with executable queries, verified programs and expert feedback can give clinicians auditable access to trial evidence.
Artificial Intelligence (cs.AI)
arXiv:2610.02576 [cs.AI]
(or arXiv:2610.02576v1 [cs.AI] for this version)
https://doi.org/10.48550/arXiv.2610.02576 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 250 words
Related coverage
J++ Lens: Jacobian Filtering Enables More Faithful Workspace Lenses
LessWrong · Oct 8, 2026

Biomedical Imaging's Real Bottleneck Is the Data, Not the Model
Databricks · Oct 8, 2026
Enabling a new model for healthcare with AI co-clinician
Google DeepMind · Apr 30, 2026

What We Learned Trying to Catch AI Liars: An Aletheia's Quest Retrospective
EleutherAI · Aug 25, 2026